Literature DB >> 3285481

The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer.

K B Horwitz1.   

Abstract

This article summarizes the role of progesterone receptors (PgRs) as markers of hormone-dependent breast cancers and the use of progestational agents in breast cancer treatment. We discuss the structure of PgRs, their purification, the production of anti-PgR monoclonal antibodies, and the use of these antibodies for clinical assays.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3285481

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  4 in total

1.  Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.

Authors:  S De Placido; C Gallo; A Marinelli; F Perrone; C Pagliarulo; G Petrella; G Delrio; M D'Istria; L Del Mastro; A R Bianco
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

2.  Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.

Authors:  G Gasparini; F Pozza; R Dittadi; S Meli; S Cazzavillan; P Bevilacqua
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status.

Authors:  Jennifer A Rusiecki; Theodore R Holford; Shelia H Zahm; Tonzhang Zheng
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology.

Authors:  G Ursin; L Bernstein; S J Lord; R Karim; D Deapen; M F Press; J R Daling; S A Norman; J M Liff; P A Marchbanks; S G Folger; M S Simon; B L Strom; R T Burkman; L K Weiss; R Spirtas
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.